NORACEF

This brand name is authorized in Nigeria.

Active ingredients

The drug NORACEF contains one active pharmaceutical ingredient (API):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1964	Powder for injection	Noracef Injection INJ_PWD 1000 mg 1 X 1VIAL + 2ML LIDOCAINE HYDROCHLORIDE 1%	Noracef Injection C4-1964 Noracef CEFTRIAXONE SODIUM ANTIBIOTIC CEFTRIAXONE SODIUM USP EQ. TO CEFTRIAXONE 1000MG INJECTION 1 X 1VIAL + 2ML LIDOCAINE HYDROCHLORIDE 1% PRESCRIPTION ONLY MEDICINE TREATMENT OF BACTERIAL INFECTION CAUSED BY SUSCEPTIBLE MICROORGANISM MEDNORAL PHARMACEUTICALS LTD, NIGERIA INJECT CARE PARENTERALS PVT LTD, INDIA 01/27/2022 01/26/2027	27/01/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1964